Small-Cap Specialists Issues Research Report on Medical Marijuana Stocks: (OTCQB: CBIS), (OTCQB: XCHC), and (OTCQB: PHOT)
Small Cap Specialists Issues Research Reports on Small-Caps Showing Growth Potential in the Marijuana Periphery Sector
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 02/15/13 -- (OTCQB: CBIS) is a development stage company, engaged in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. They primarily focus on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance.
52 week price range: $.03 - $.2455/share
Volume (3 month) 8.6 million shares/day
Market cap: $51 million
The November elections counted 18 states electing to legalize marijuana for medicinal purposes and two states decriminalizing recreational use. CBIS has drugs in the development stage to treat ailments not being considered by its mainstream competitors. The company is located in Colorado were marijuana is legal for both medicinal and recreational use. Get our full report on this specific sector of the medical marijuana industry.
(OTCQB: XCHC) is U.S. Boutique Company whose niche is cannabis and hemp based extracts and products that target medical cannabis, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. There are some exciting developments in process now that could really provide a launching pad for this small company. The Company issues a stronger outlook for 2013 based on new Phytiva Brand product lines for the Medical Cannabis Industry as a whole. These new Phytiva product lines will be launched with Cannabis based formulations through Medical Cannabis dispensaries, Cannabis laboratories, and individual legal state or legal foreign grow operations on a jurisdiction by jurisdiction approved basis. Get the full report and more on the recently announced joint venture with Cannabis Science, Inc. (Get the full research report)
(OTCQB: PHOT) manufactures and markets horticulture products for the indoor gardening industry. They offer hi-powered light emitting diode (LED) grow light products and plant growing systems along with accessories. PHOT sells its products under the Phototron and Stealth Grow LED brand names through approximately 2,500 hydroponic retailers and on-line resellers. They also operate an online site, Greners.com.
Market Cap: $25 million
Shares Outstanding: 343 million (a/o 11-15-12)
52 week range: $.01 - $.25/share
Avg. (3 month) volume: 5 million shares daily
The share price bottomed out in October and has risen steadily since then with a spike in the past week. (Get the full report)
Small-Cap Specialists LLC employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This press release is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the companies listed here.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.02.2013 - 09:28 Uhr
Sprache: Deutsch
News-ID 1197589
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Equipment & Supplies
Anmerkungen:
Diese Pressemitteilung wurde bisher 181 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Small-Cap Specialists Issues Research Report on Medical Marijuana Stocks: (OTCQB: CBIS), (OTCQB: XCHC), and (OTCQB: PHOT)
"
steht unter der journalistisch-redaktionellen Verantwortung von
Small-Cap Specialists LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
